TickerFactsScreenerDevelopers

RIGEL PHARMACEUTICALS INC (RIGL) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $46.01M2009: $14.72M2010: $8.88M2011: $18.63M2012: $33.48M2013: $20.85M2014: $15.20M2015: $43.46M2016: $17.63M2017: $38.29M2018: $76.32M2019: $22.52M2020: $30.37M2021: $18.89M2022: $24.46M2023: $32.79M2024: $56.75M2025: $40.58M$40.58M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$40.58M-28.5%
2024$56.75M+73.1%
2023$32.79M+34.0%
2022$24.46M+29.5%
2021$18.89M-37.8%
2020$30.37M+34.9%
2019$22.52M-70.5%
2018$76.32M+99.3%
2017$38.29M+117.2%
2016$17.63M-59.4%
2015$43.46M+185.8%
2014$15.20M-27.1%
2013$20.85M-37.7%
2012$33.48M+79.7%
2011$18.63M+109.9%
2010$8.88M-39.7%
2009$14.72M-68.0%
2008$46.01M—